BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC
Position in NTLA — Intellia Therapeutics, Inc.
CIK 1352860
BLUE BELL, PA
Position in NTLA
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$22,524
+$6,729 QoQ
Shares Held
1,757
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 60%
Shared 0%
None 40%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC holds $143,116 across 6 Biotechnology names. NTLA ranks #2 (15.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRME |
Prime Medicine, Inc.
|
27,015 | $94,012 | |
| 2 | NTLA |
Intellia Therapeutics, Inc.
This page
|
1,757 | $22,524 | |
| 3 | INCY |
Incyte Corp
|
139 | $13,082 | |
| 4 | ARQT |
Arcutis Biotherapeutics, Inc.
|
369 | $8,693 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
101 | $4,804 | |
| 6 | ITRMF |
Iterum Therapeutics plc
|
66 | $1 |
All Filings in NTLA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $22,524 | 1,757 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $15,795 | 1,757 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $30,343 | 1,757 | Shares | Sole | 2025-10-22 | |
| No filing history on record for this holder in this stock. | ||||||